Psychiatry / mental health clinical trials recruiting in Illinois

77 recruiting psychiatry / mental health trials match in Illinois. Showing 20.

• Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderRecruiting

  Phase 3 · Alkermes, Inc. · Chicago, Illinois

• Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer SurvivorsRecruiting

  N/A · Northwestern University · Chicago, Illinois

• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderRecruiting

  Phase 3 · Intra-Cellular Therapies, Inc. · Naperville, Illinois

• A Study to Evaluate the Effect of KarXT on Urological SafetyRecruiting

  Phase 4 · Bristol-Myers Squibb · Chicago, Illinois

• A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderRecruiting

  Phase 2 · Syndeio Biosciences, Inc · Chicago, Illinois

• Device for Treating Generalized AnxietyRecruiting

  N/A · BTL Industries Ltd. · Chicago, Illinois

• Developing a Digital Intervention for Adolescent Nonsuicidal Self-injuryRecruiting

  N/A · Northwestern University · Chicago, Illinois

• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsRecruiting

  Phase 4 · Axsome Therapeutics, Inc. · Chicago, Illinois

• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)Recruiting

  Phase 3 · Bristol-Myers Squibb · Chicago, Illinois

• Executive Function and Parenting in ChildhoodRecruiting

  N/A · University of Illinois at Chicago · Chicago, Illinois

• A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)Recruiting

  Phase 3 · Definium Therapeutics US, Inc. · Chicago, Illinois

• A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderRecruiting

  Phase 2 · AbbVie · Chicago, Illinois

• Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Recruiting

  Phase 2 · Autobahn Therapeutics, Inc. · Birmingham, Alabama

• A Study of Brenipatide in Adult Participants With SchizophreniaRecruiting

  Phase 2 · Eli Lilly and Company · Chicago, Illinois

• Maternal Mindfulness: Depression and Postpartum PainRecruiting

  N/A · University of Illinois at Urbana-Champaign · Champaign, Illinois

• A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderRecruiting

  Phase 3 · Xenon Pharmaceuticals Inc. · Phoenix, Arizona

• A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXTRecruiting

  Phase 1 · Bristol-Myers Squibb · Chicago, Illinois

• Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With SchizophreniaRecruiting

  Phase 2 · Novartis Pharmaceuticals · Chicago, Illinois

• A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive DisorderRecruiting

  Phase 3 · Eli Lilly and Company · Chicago, Illinois

• A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With SchizophreniaRecruiting

  Phase 2 · Kynexis B.V. · Chicago, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.